Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Bekkenk

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 25, 2001
[CD56-positive 'natural killer'/T-cell lymphoma]M W Bekkenk, R Willemze
Journal of the American Academy of Dermatology|September 25, 2001
Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?M H Vermeer, M W Bekkenk, R Willemze
Journal of Internal Medicine|April 1, 1997
Internal jugular vein thrombosis after cervical tractionT A Simmers, M W Bekkenk, M Vidakovic-Vukic
Cancer|August 22, 2000
Frequency of central nervous system involvement in primary cutaneous B-cell lymphomaM W Bekkenk, T J Postma, C J Meijer, et al.
The British Journal of Dermatology|July 30, 2020
What is successful repigmentation in vitiligo from the point of view of patients?V S Narayan, S E Uitentuis, M W Bekkenk, et al.
Lasers in Medical Science|May 31, 2022
Laser- and intense pulsed light (IPL)-induced vitiligo patches: a systematic review of the literature - short reportN F Post, N X Van Broekhoven, M W Bekkenk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literatureM W Bekkenk, P M Jansen, C J L M Meijer, et al.
The British Journal of Dermatology|September 5, 2001
Lymphomatoid papulosis with a natural killer-cell phenotypeM W Bekkenk, P M Kluin, P M Jansen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
Patients' perspective on current treatments and demand for novel treatments in vitiligoV S Narayan, S E Uitentuis, R M Luiten, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2016
Focal vitiligo: long-term follow-up of 52 casesJ E Lommerts, Y Schilder, M A de Rie, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|September 25, 2001
[CD56-positive 'natural killer'/T-cell lymphoma]M W Bekkenk, R Willemze
Journal of the American Academy of Dermatology|September 25, 2001
Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?M H Vermeer, M W Bekkenk, R Willemze
Journal of Internal Medicine|April 1, 1997
Internal jugular vein thrombosis after cervical tractionT A Simmers, M W Bekkenk, M Vidakovic-Vukic
Cancer|August 22, 2000
Frequency of central nervous system involvement in primary cutaneous B-cell lymphomaM W Bekkenk, T J Postma, C J Meijer, et al.
The British Journal of Dermatology|July 30, 2020
What is successful repigmentation in vitiligo from the point of view of patients?V S Narayan, S E Uitentuis, M W Bekkenk, et al.
Lasers in Medical Science|May 31, 2022
Laser- and intense pulsed light (IPL)-induced vitiligo patches: a systematic review of the literature - short reportN F Post, N X Van Broekhoven, M W Bekkenk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literatureM W Bekkenk, P M Jansen, C J L M Meijer, et al.
The British Journal of Dermatology|September 5, 2001
Lymphomatoid papulosis with a natural killer-cell phenotypeM W Bekkenk, P M Kluin, P M Jansen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
Patients' perspective on current treatments and demand for novel treatments in vitiligoV S Narayan, S E Uitentuis, R M Luiten, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2016
Focal vitiligo: long-term follow-up of 52 casesJ E Lommerts, Y Schilder, M A de Rie, et al.
Pageof 5